PLD3 and Alzheimer disease: A major focus for future studies could be to investigate to what extent PLD3 SNPs contribute to the exacerbated inflammatory state that is characteristic of AD progression and to what extent activated nucleotide signaling pathways, as shown in this study, are involved.